• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他汀类药物与肝脏。

Statins and liver.

出版信息

Cas Lek Cesk. 2022 Spring;161(2):80-83.

PMID:35728963
Abstract

Statins are widely accepted hypolipidemics that work by inhibiting hydroxymethylglutaryl coenzyme A reductase and thereby inhibiting cholesterol synthesis. They significantly reduce cardiovascular risk. Their use could be associated with side effects, which are serious only in rare cases. However, an unhealthy lifestyle, obesity, and elevation of blood lipids do not only damage the cardiovascular system. The current topic not only in hepatology is non-alcoholic fatty liver disease - NAFLD. The aim of this article is, among others, to draw attention to the pleiotropic effects of statins, which could be used in the treatment of this disease in the future. Recent studies have suggested that the administration of statins to patients with NAFLD is beneficial.

摘要

他汀类药物是广泛接受的降脂药物,通过抑制羟甲基戊二酰辅酶 A 还原酶从而抑制胆固醇合成。它们显著降低心血管风险。他汀类药物的使用可能与副作用相关,但这些副作用仅在极少数情况下较为严重。然而,不健康的生活方式、肥胖和血脂升高不仅会损害心血管系统。目前,非酒精性脂肪性肝病(NAFLD)不仅是肝病学的热门话题。本文的目的除其他外,还在于提请人们注意他汀类药物的多效性作用,这些作用将来可能会被用于治疗这种疾病。最近的研究表明,对 NAFLD 患者给予他汀类药物治疗是有益的。

相似文献

1
Statins and liver.他汀类药物与肝脏。
Cas Lek Cesk. 2022 Spring;161(2):80-83.
2
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.他汀类药物单独使用,或与吡格列酮及其他药物联合使用,用于治疗非酒精性脂肪性肝病/非酒精性脂肪性肝炎及相关心血管风险。专家小组声明。
Metabolism. 2017 Jun;71:17-32. doi: 10.1016/j.metabol.2017.02.014. Epub 2017 Mar 4.
3
Under-prescription of statins in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者他汀类药物处方不足。
Nutr Metab Cardiovasc Dis. 2017 Feb;27(2):161-167. doi: 10.1016/j.numecd.2016.09.011. Epub 2016 Sep 28.
4
Nonalcoholic fatty liver disease and statins.非酒精性脂肪性肝病与他汀类药物
Metabolism. 2015 Oct;64(10):1215-23. doi: 10.1016/j.metabol.2015.07.003. Epub 2015 Jul 8.
5
Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk.他汀类药物:预防和治疗非酒精性脂肪性肝病或非酒精性脂肪性肝炎及相关心血管风险的被低估的资产。
Curr Vasc Pharmacol. 2018;16(3):246-253. doi: 10.2174/1570161115666170621082910.
6
The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease.他汀类药物在非酒精性脂肪性肝病治疗中的作用。
Curr Pharm Des. 2018;24(38):4587-4592. doi: 10.2174/1381612825666190117114305.
7
Statins in liver disease: not only prevention of cardiovascular events.他汀类药物在肝病中的应用:不仅用于预防心血管事件
Expert Rev Gastroenterol Hepatol. 2018 Aug;12(8):743-744. doi: 10.1080/17474124.2018.1477588. Epub 2018 May 24.
8
Statins Are Underused in Women With NAFLD After Cardiovascular Events Compared With Matched Control Subjects.与匹配的对照受试者相比,心血管事件后 NAFLD 女性中他汀类药物的使用率较低。
Clin Gastroenterol Hepatol. 2023 May;21(5):1359-1361.e2. doi: 10.1016/j.cgh.2022.03.020. Epub 2022 Mar 24.
9
Are statins 'IDEAL' for non-alcoholic fatty liver disease?他汀类药物对非酒精性脂肪性肝病是否“理想”?
Curr Med Res Opin. 2014 Feb;30(2):229-31. doi: 10.1185/03007995.2013.855192. Epub 2013 Oct 28.
10
Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes.他汀类药物与精准医学时代的非酒精性脂肪性肝病:益友而非敌友。
Atherosclerosis. 2019 May;284:66-74. doi: 10.1016/j.atherosclerosis.2019.02.028. Epub 2019 Mar 3.

引用本文的文献

1
Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease.探讨神经酰胺和鞘氨醇-1-磷酸在非酒精性脂肪性肝病中的作用和发病机制。
Int J Biol Sci. 2023 Jan 1;19(1):311-330. doi: 10.7150/ijbs.78525. eCollection 2023.